🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Retrospective studies indicate that active surveillance for clinically loca...
Status
Recruiting
Location
Johns Hopkins Hospital
Start Date
2009-01
Trial ID
NCT02346435
The purpose of this study is to determine if the novel TR approach is super...
Status
Completed
Location
Kantonsspital Baden
Start Date
2022-05-15
Trial ID
NCT05377632
Treatments Being Tested
Ablative treatments are believed to have a lower rate of complications, sho...
Status
Recruiting
Location
Karolinska University Hospital
Start Date
2024-01-31
Trial ID
NCT06278506
Partial Nephrectomy is the standard care for small (\<4 cm) renal tumors. D...
Status
Unknown
Location
Rabin medical center
Start Date
2009-09
Trial ID
NCT01093079
Treatments Being Tested
The purpose of this clinical investigation was to evaluate the safety and p...
Status
Completed
Location
Hospital Clínic de Barcelona
Start Date
2023-11-01
Trial ID
NCT06119568
A retrospective, population-based analysis examining the rates of robotic s...
Status
Completed
Location
Sunnybrook Health Sciences Centre
Start Date
2018-07-01
Trial ID
NCT05211128
Treatments Being Tested
BACKGROUND: The role of cytoreductive nephrectomy (CN) in the treatment of ...
Status
Recruiting
Location
Gangnam Severance Hospital
Start Date
2023-07
Trial ID
NCT05753839
To demonstrate that Robotic-Assisted partial nephrectomy is superior to Ope...
Status
Terminated
Location
Dept. of Urology, University Hospital Tübingen
Start Date
2019-03-12
Trial ID
NCT03849820
Treatments Being Tested
BACKGROUND: For synchronous metastatic renal cell carcinoma (RCC), surgical...
Status
Recruiting
Location
Department of Oncology, Aarhus University Hospital
Start Date
2020-07-06
Trial ID
NCT03977571
Treatments Being Tested
Axitinib (AXITINIB) is an oral, potent, and selective inhibitor of vascular...
Status
Completed
Location
Bicêtre Hospital
Start Date
2012-02
Trial ID
NCT02597322
Treatments Being Tested